Generic Threat

While human infections of the virus are rare, a strain recently appeared in dairy cows before infecting a human in Texas.

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Rahman discusses the new opportunities that digital twins present to researchers.

Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.